SFP
CSCI

Sandbox Financial Partners’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Sandbox Financial Partners’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-195
Closed -$8K – 92
2020
Q4 		$8K Buy
+195
New +$7.22K 0.01% 69

Other funds holding CSCI

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Sandbox Financial Partners's CSCI Position: Q1 2021 in Review

Sandbox Financial Partners sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q1 2021, closing a stake of 195 shares — an estimated $8K sold.

Sandbox Financial Partners first reported a position in CSCI in Q4 2020 and held it in 1 quarter. The position peaked at $8K in Q4 2020. 31 funds tracked by Wall St. Rank hold CSCI as of Q1 2021.

  • Sandbox Financial Partners reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Sandbox Financial Partners sold 195 COSCIENS Biopharma Inc. Common Stock shares in Q1 2021, an estimated $8K.
  • Sandbox Financial Partners first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Sandbox Financial Partners's COSCIENS Biopharma Inc. Common Stock position peaked at $8K in Q4 2020.
  • 31 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q1 2021.

Based on Sandbox Financial Partners's 13F filing for Q1 2021, filed 7 May 2021.